Literature DB >> 30482646

Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013.

Minghuan Wang1, Xiang Luo1, Shabei Xu1, Wenhua Liu2, Fengfei Ding1, Xiaoxiang Zhang3, Liang Wang3, Jian Liu4, Jianping Hu5, Wei Wang6.   

Abstract

BACKGROUND: China is the world's largest consumer of tobacco and has a large smoking-related chronic disease burden. In this nationwide study, we aimed to evaluate smoking prevalence and its implication on chronic diseases in the Chinese population.
METHODS: We collected data from serial cross-sectional National Health Service Surveys done in China in 2003, 2008, and 2013. These surveys cover all 31 provinces, autonomous regions, and municipalities in mainland China, and use multistage stratified cluster sampling. We divided mainland China into east, central, and west regions and then sampled counties from each region stratified by urban and rural areas. All respondents aged 15 years or older in the selected households were eligible. We analysed the variation in smoking prevalence from 2003 to 2013, further identified risk factors for smoking, and assessed the association between smoking and chronic diseases by using multiple logistic regression.
FINDINGS: The number of individuals interviewed and involved in the study was 153 450 in 2003, 145 223 in 2008, and 229 676 in 2013. The standardised smoking prevalence in China was consistently high, with a proportion of current smokers of 26·0% (95% CI 25·8-26·2) in 2003, 24·9% (24·8-25·1) in 2008, and 25·2% (25·1-25·4) in 2013 (p value for trend 0·5062). For men, prevalence was 48·4% (48·1-48·7) in 2003, 47·0% (46·6-47·4) in 2008, and 47·2% (46·9-47·5) in 2013. For women, prevalence was 3·1% (3·0-3·2) in 2003, 2·3% (2·2-2·5) in 2008, and 2·7% (2·6-2·8) in 2013. Smoking prevalence varied in different regions, and we identified four major patterns. While a consistently high proportion of Chinese men smoked, the standardised smoking prevalence in women younger than 40 years increased from 1·0% in 2003 to 1·6% in 2013. Moreover, the smoking prevalence among adolescent smokers aged 15-24 years increased from 8·3% in 2003 to 12·5% in 2013. Alcohol consumption was closely linked to smoking in adolescents (odds ratio 7·5, 95% CI 6·9-8·1). Risk factors for adolescent smoking were having older family members who smoke (1·9, 1·8-1·9) and low level education (1·3, 1·2-1·4). Increased risks of chronic diseases were related to smoking (1·1, 1·0-1·1), with higher risks related to early smoking initiation (1·1, 1·0-1·1) and long-term smoking (1·2, 1·2-1·3).
INTERPRETATION: The implementation of tobacco control policies in China since the signing of the WHO Framework Convention on Tobacco Control in 2003 has not been effective in reducing smoking prevalence. Smoking prevalence among adolescents of both genders has increased substantially and there has been a steady increase among young women. More practical and effective policies targeting adolescents and women are urgently needed. Action is needed to prevent the large and growing smoking-related chronic disease burden further increasing as China's population ages. FUNDING: National Health Commission of the People's Republic of China.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30482646     DOI: 10.1016/S2213-2600(18)30432-6

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  83 in total

1.  The changes of brain functional networks in young adult smokers based on independent component analysis.

Authors:  XianFu Wang; Ting Xue; Fang Dong; Yangding Li; Dongdong Xie; Chang Liu; Ming Zhang; Yanzhi Bi; Kai Yuan; Dahua Yu
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

2.  COVID-19: the heart and other issues.

Authors:  Cormac T O'Connor; David Mulcahy
Journal:  Br J Cardiol       Date:  2020-07-11

3.  Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030.

Authors:  Yuan Fang; Zhen Li; Hui Chen; Tongchao Zhang; Xiaolin Yin; Jinyu Man; Xiaorong Yang; Ming Lu
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-29       Impact factor: 4.322

4.  Colorectal Cancer Incidence and Mortality Trends and Analysis of Risk Factors in China from 2005 to 2015.

Authors:  Chao Sun; Yan Liu; Yiman Huang; Bang Li; Weiqing Rang
Journal:  Int J Gen Med       Date:  2021-12-20

5.  A systematic surgical approach for the treatment of idiopathic granulomatous mastitis: a case series.

Authors:  Xiaohui Zhang; Yan Li; Yidong Zhou; Deshun Liu; Linlin Chen; Kunying Niu; Qiang Sun; Hanyuan Huang
Journal:  Gland Surg       Date:  2020-04

6.  Barriers to blood pressure control in China in a large opportunistic screening.

Authors:  Xin Chen; Shao-Kun Xu; Qian-Hui Guo; Zhe Hu; Hong-Yu Wang; Jing Yu; Wei-Hua Li; Guo-Bao Tang; Hai-Feng Zhang; Yan Li; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-09       Impact factor: 3.738

7.  Association of smoking and cardiovascular disease with disease progression in COVID-19: A systematic review and meta-analysis.

Authors:  Shiwei Kang; Xiaowei Gong; Yadong Yuan
Journal:  Epidemiol Infect       Date:  2021-05-12       Impact factor: 2.451

8.  Links Between Mortality and Socioeconomic Characteristics, Disease Burden, and Biological and Physical Functioning in the Aging Chinese Population.

Authors:  Yuan S Zhang; John A Strauss; Peifeng Hu; Yaohui Zhao; Eileen M Crimmins
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-02-03       Impact factor: 4.942

9.  Disability-adjusted life years associated with population ageing in China, 1990-2017.

Authors:  Ruotong Li; Xunjie Cheng; David C Schwebel; Yang Yang; Peishan Ning; Peixia Cheng; Guoqing Hu
Journal:  BMC Geriatr       Date:  2021-06-16       Impact factor: 3.921

10.  An assessment of anthropometric indices and its association with NCDs among the older adults of India: evidence from LASI Wave-1.

Authors:  Mahadev Bramhankar; Mohit Pandey; Gursimran Singh Rana; Balram Rai; Nand Lal Mishra; Anandi Shukla
Journal:  BMC Public Health       Date:  2021-07-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.